Overview
Jan-mathijs Schoffelen practices practicing medicine in Nijmegen, Netherlands.
Their clinical expertise encompasses Epilepsy Juvenile Absence and Drug Induced Dyskinesia.
They are actively involved in clinical research, co-authoring 66 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jan-mathijs M. Schoffelen
Is Jan-mathijs M. Schoffelen a top-rated expert for Epilepsy Juvenile Absence?
MediFind is an objective health platform that identifies experts based on real-world data. Jan-mathijs M. Schoffelen is classified as an Experienced expert for Epilepsy Juvenile Absence, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jan-mathijs M. Schoffelen participate in research or clinical trials?
Yes. Jan-mathijs M. Schoffelen has published 66 articles and abstracts on conditions like Epilepsy Juvenile Absence. You can view a list of Jan-mathijs M. Schoffelen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Drug Induced DyskinesiaSchoffelen isExperienced. Learn about Drug Induced Dyskinesia.
- Epilepsy Juvenile AbsenceSchoffelen isExperienced. Learn about Epilepsy Juvenile Absence.